BUSINESS
Wockhardt surges on initiating global Phase III clinical study of WCK 5222
Wockhardt is currently trading at Rs. 234.40, up by 3.40 points or 1.47% from its previous closing of Rs. 231.00 on the BSE. The scrip opened at Rs.…
wockhardt
BUSINESS
Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines
Wockhardt has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light…
BUSINESS
Wockhardt reports consolidated net loss of Rs 23 crore in Q2
Wockhardt has reported results for second quarter ended September 30, 2018. The company has reported a fall of 79.86% in its net…
BUSINESS
Wockhardt gets nod to raise Rs 1,800 crore on private placement
Wockhardt has received approval for raising of funds through issuance of Non-Convertible Debentures (NCDs)/ Bonds (secured/ unsecured) on private placement basis up…